about
The effects of psychostimulant drugs on blood brain barrier function and neuroinflammationMethamphetamine-induced toxicity: an updated review on issues related to hyperthermiaMephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake ratsMethamphetamine exposure and chronic illness in police officers: significant improvement with sauna-based detoxification therapyNeurologic manifestations of chronic methamphetamine abuseAgmatine attenuates the discriminative stimulus and hyperthermic effects of methamphetamine in male ratsDifferential effects of environment-induced changes in body temperature on modafinil's actions against methamphetamine-induced striatal toxicity in miceDetermination of psychostimulants and their metabolites by electrochemistry linked on-line to flowing atmospheric pressure afterglow mass spectrometry.The levels of triglyceride and total cholesterol in methamphetamine dependenceMethamphetamine causes sustained depression in cerebral blood flowThe clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine.Can We Selectively Reduce Appetite for Energy-Dense Foods? An Overview of Pharmacological Strategies for Modification of Food Preference BehaviorMethamphetamine-associated cardiomyopathy.Multivariate analysis of subjective responses to d-amphetamine in healthy volunteers finds novel genetic pathway associationsPsychostimulant addiction treatment.Symptomatic Exposures Among California Inmates 2011-2013.Effect of Abstinence on Depression, Anxiety, and Quality of Life in Chronic Methamphetamine Users in a Therapeutic Community.Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammationNeurologic manifestations of chronic methamphetamine abuse.A Mouse Model for Binge-Level Methamphetamine Use.Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR).Perioperative temperature elevation: not all hyperthermia is malignant hyperthermia.Nephrotoxic effects of designer drugs: synthetic is not better!Metabolomics of Methylphenidate and Ethylphenidate: Implications in Pharmacological and Toxicological Effects.Effects of acute and chronic systemic methamphetamine on respiratory, cardiovascular and metabolic function, and cardiorespiratory reflexes.MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?The outcome of agitation in poisoned patients in an Iranian tertiary care university hospitalPancreatitis Induced by Cocaine.Accidental overdose in the deep shade of night: a warning on the assumed safety of 'natural substances'Differentiating between the course of illness in bipolar 1 and chronic-psychotic heroin-dependent patients at their first agonist opioid treatment.The evaluation of AZ66, an optimized sigma receptor antagonist, against methamphetamine-induced dopaminergic neurotoxicity and memory impairment in mice.On the necessity of translational cognitive-neurotoxicological research in methamphetamine abuse and addiction.Alteration of catecholamine concentrations in rat testis after methamphetamine exposure.Targeting misuse of 2-amino-N-ethyl-1-phenylbutane in urine samples: in vitro-in vivo correlation of metabolic profiles and development of LC-TOF-MS method.Interaction and Transport of Methamphetamine and its Primary Metabolites by Organic Cation and Multidrug and Toxin Extrusion Transporters.The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment.Association of leukocytosis with amphetamine and cocaine use
P2860
Q21129283-26948106-2912-4C09-B9B7-0FB1F61D37DCQ23919891-74F09B76-CAAD-4C41-9345-0A22396A9F7DQ24617723-DA0FFDE5-6599-4F73-AD1A-46DCEE645EA9Q24620212-CC0AADCF-059C-495D-8D35-654DAFA147DEQ24624506-2D7473E6-34F0-4E8E-B5F9-035E196F5AE7Q28385342-CEF92999-4AC9-4675-B7CA-859CF5F9E71EQ28397225-EB462B68-BF14-4B44-B058-EF732F2D2D80Q33462218-CA7328D0-CB4D-47FA-8A0B-0B80F0D25B32Q33606159-DC2F4D9E-9BEC-4E83-A234-C90D3C8E1794Q33771269-8AE5E662-B4DA-4DE7-ABE1-6D87780E99C7Q34178580-7A7155FB-EF20-480B-A639-4321605EC6E3Q34501087-86CE37F0-9032-47B0-86D5-F03DC64B76C9Q35057922-004ED6CC-C4F7-4448-B411-E376C197EAA9Q35858745-9B984C16-02E2-47FF-8DE6-687F6F98FD71Q35915231-D4672EE9-E19F-406E-9A60-B4692CE143CEQ35991857-BA7E7A84-65D9-451C-993C-801D0AD915E1Q36173333-D0D2A325-6A07-4E85-A41F-9FC9DE349EC2Q36278826-B468FE41-FA49-4CBE-AD48-55A5663AC6EDQ37150547-7B592E38-0623-4F0F-838B-CE7EC75249B1Q37385658-A0F39F8F-4D9F-4C5C-922D-36816EF2FFB0Q37673496-91B87FB0-94CF-4AFD-B51F-E9E81A528425Q38124469-8BE79856-AB09-4608-B7E1-E611F348CA80Q38198873-75E4478C-45D5-4BBE-B919-4D8FFF9426ECQ38903401-4193ACB1-6BA6-438D-8778-889A2330CCD7Q40301697-5AAB2425-9D6A-4F03-AEA4-B7A613190BCBQ41248604-D290AD25-8B99-4E56-A669-D899A2106D8FQ41639858-86944B7C-DB37-44C8-99A1-52CB45CFC9F5Q42256472-5AA70AE3-3203-4686-A9E5-F16ECB2885D2Q42592684-88E308C3-D1D6-4FB9-947F-1963D7C4A3EAQ44348272-508B14FF-8282-486F-B050-B7BE16F871F8Q44920824-B2253F13-3AF3-4064-9B1F-BD87FF78BAF7Q47739836-606069E8-9842-4EC5-A283-81482A6900C4Q48743877-A960F1E9-0D8E-4E1E-A4C3-20D6EC6FF531Q51744662-02309BD3-0FD9-4F94-A75B-06461564B6A0Q52675161-A29310F4-D042-48D3-AE90-614858F785B3Q55284097-1EA3DA1F-350C-4F9F-8DE6-5E52B1056AA6Q59074943-6DBB25A4-76AB-46B3-900E-A461AA49A5D4
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The clinical toxicology of metamfetamine
@ast
The clinical toxicology of metamfetamine
@en
The clinical toxicology of metamfetamine
@en-gb
The clinical toxicology of metamfetamine
@nl
type
label
The clinical toxicology of metamfetamine
@ast
The clinical toxicology of metamfetamine
@en
The clinical toxicology of metamfetamine
@en-gb
The clinical toxicology of metamfetamine
@nl
prefLabel
The clinical toxicology of metamfetamine
@ast
The clinical toxicology of metamfetamine
@en
The clinical toxicology of metamfetamine
@en-gb
The clinical toxicology of metamfetamine
@nl
P2093
P2860
P3181
P1433
P1476
The clinical toxicology of metamfetamine
@en
P2093
D. Michael G. Beasley
Leo J. Schep
Robin J. Slaughter
P2860
P304
P3181
P356
10.3109/15563650.2010.516752
P407
P577
2010-08-01T00:00:00Z